I think theres always going to be pressures: before us, it was celebrities that people compared themselves with
Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), tirzepatide injection at $289/mo (or $249/mo on the 6-month plan), and oral formulations are $289/mo month-to-month, or from $249/mo on the 6-month plan-$349 per month depending on the compound
78.6 4.4 l/min/gkw, sodium excretion 7.4 0.8 vs
Future research, she added, could investigate the long-term impacts of switching from GLP-1 receptor agonists to phentermine
Resmetirom (Rezdiffra TM ), a liver-directed thyroid hormone receptor- (THR-) agonist, received accelerated FDA approval in March 2024 as the first agent specifically indicated for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2-F3), based on the MAESTRO-NASH trial demonstrating MASH resolution and fibrosis improvement